Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) was the recipient of a large decline in short interest in October. As of October 15th, there was short interest totalling 124,400 shares, a decline of 44.4% from the September 30th total of 223,600 shares. Based on an average trading volume of 536,000 shares, the days-to-cover ratio is currently 0.2 days.
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group stock traded down $0.22 during mid-day trading on Friday, reaching $12.48. 2,782,880 shares of the company traded hands, compared to its average volume of 823,897. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97. Reckitt Benckiser Group has a fifty-two week low of $10.24 and a fifty-two week high of $15.03. The firm's fifty day moving average is $12.04 and its two-hundred day moving average is $11.45.
Analyst Ratings Changes
Several research analysts recently commented on the stock. UBS Group upgraded shares of Reckitt Benckiser Group to a "strong-buy" rating in a research note on Wednesday, September 18th. Citigroup upgraded shares of Reckitt Benckiser Group to a "strong-buy" rating in a research note on Tuesday, October 1st. JPMorgan Chase & Co. lowered shares of Reckitt Benckiser Group from an "overweight" rating to a "neutral" rating in a research note on Thursday, August 29th. Finally, Barclays upgraded shares of Reckitt Benckiser Group to a "strong-buy" rating in a research note on Friday, October 4th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, one has issued a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat.com, Reckitt Benckiser Group presently has a consensus rating of "Moderate Buy".
Get Our Latest Stock Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Company Profile
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
See Also
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
